Peter Bluford Net Worth & Insider Trades
Peter Bluford - VP, Sangamo Biosciences Inc
What is Peter Bluford's Net Worth?
The current estimated net worth of Sangamo Biosciences Inc's VP, Peter Bluford, is estimated to be about $462K . Peter Bluford owns about 136,191 units of Sangamo Biosciences Inc common stock. In the last year at Sangamo Biosciences Inc, Peter Bluford has sold an estimated value of $125.93K worth.
What is Peter Bluford's Past Insider Trading?
Peter Bluford's largest sale order was 1,000 units , worth over $7.5K on January 14, 2004. In total, Peter Bluford has made about 43 transactions over a year of their time at Sangamo Biosciences Inc. Peter Bluford usually trades in April, March, June, January and December, with the busiest year in 2004. The most recent transaction was a sale order of 500 units , worth over $2.5K on October 6, 2004.
PETER BLUFORD
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Peter Bluford's' Mailing Address?
- Mailing address is C/o Sangamo Biosciences In Ste.A-100 Point Richmond Tech Center 501 Cana Blvd Richmond CA 94804 CA
Sangamo Biosciences Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Alexander D. Macrae | 2020 | $681,797 | - | $1,147,500 | $1,488,746 | $511,348 | $5,639 | $3,835,030 |
| Alexander D. Macrae | 2019 | $661,939 | - | $571,148 | $2,274,230 | $436,880 | $42,358 | $3,986,555 |
| Alexander D. Macrae | 2018 | $636,480 | - | $631,575 | $2,410,657 | $420,077 | $5,639 | $4,104,428 |
| Sung H. Lee | 2020 | $438,262 | - | $340,000 | $443,316 | $215,000 | $5,639 | $1,442,217 |
| Sung H. Lee | 2019 | $72,500 | $200,000 | $452,813 | $1,757,679 | $47,415 | $273 | $2,530,680 |
| Gary H. Loeb | 2020 | $406,000 | - | $340,000 | $441,110 | $200,564 | $5,639 | $1,393,313 |
| Gary H. Loeb | 2019 | $166,667 | - | - | $1,788,475 | $87,200 | $683 | $2,043,025 |
| D. Mark McClung | 2020 | $276,667 | $150,000 | $916,000 | $1,187,220 | $136,245 | $5,093 | $2,671,225 |
| R. Andrew Ramelmeier | 2020 | $416,000 | $50,000 | $374,000 | $485,221 | $203,840 | $5,639 | $1,534,700 |
| R. Andrew Ramelmeier | 2019 | $382,965 | - | $112,875 | $449,453 | $153,608 | $5,639 | $1,104,540 |
| Stéphane Boissel | 2020 | $318,283 | - | $374,000 | $485,221 | - | $256,472 | $1,433,976 |
| Stéphane Boissel | 2019 | $483,600 | - | $158,025 | $629,234 | $212,784 | $1,639 | $1,485,282 |
| Stéphane Boissel | 2018 | $120,390 | $100,000 | - | $2,052,792 | - | $316,884 | $2,590,066 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1001233/000162828021006458/sgmo_proxyx2021xdefxvs.htm
What are Sangamo Biosciences Inc's Past Insider Trades?
Sangamo Biosciences Inc's most recent insider trade came on August 31, 2022 by Biogen Inc and Biogen Ma Inc who sold 500,000 units worth $2.66M . In the last 19 years, insiders at Sangamo Biosciences Inc have sold an estimated value of $143.72M and bought an estimated value of $70.12M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are Edward Lanphier II, Director, Philip Gregory, SVP Research & CSO, and Ward Henry Wolff, Exec VP & CFO .
SANGAMO THERAPEUTICS, INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||